NCT04229043 Gastric Emptying of Water and Sports Drink in Labor
| NCT ID | NCT04229043 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beth Israel Deaconess Medical Center |
| Condition | Pregnancy |
| Study Type | INTERVENTIONAL |
| Enrollment | 108 participants |
| Start Date | 2021-02-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 108 participants in total. It began in 2021-02-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To determine the half time of the emptying of the stomach of women in early labor with and without epidural pain relief when drinking either water or a carbohydrate-based sports drink.
Eligibility Criteria
Inclusion Criteria: * Gestational age of 36 weeks or greater * American Society of Anesthesiology Physical Status 2 or 3 * Induction of labor or early labor (cervical dilation \< 6cm) * Singleton gestation Exclusion Criteria: * Recent food ingestion (\<3 hours) * Preeclampsia * Receiving magnesium sulfate * Having received narcotics within 12 hours * Diabetes mellitus * Multiple gestations * Active nausea or reflux symptoms
Frequently Asked Questions
Who can join the NCT04229043 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 50 Years, studying Pregnancy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04229043 currently recruiting?
Yes, NCT04229043 is actively recruiting participants. Visit ClinicalTrials.gov or contact Beth Israel Deaconess Medical Center to inquire about joining.
Where is the NCT04229043 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT04229043 clinical trial?
NCT04229043 is sponsored by Beth Israel Deaconess Medical Center. The trial plans to enroll 108 participants.